Afficher la notice abrégée

Novel Molecules in Diabetes Melitus, Dyslipidemia and Cardiovascular Disease

dc.contributor.editorVesa, Cosmin Mihai
dc.contributor.editorBungau, Simona Gabriela
dc.date.accessioned2023-06-23T09:46:13Z
dc.date.available2023-06-23T09:46:13Z
dc.date.issued2023
dc.identifierONIX_20230623_9783036576855_62
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/100830
dc.description.abstractThe purpose of this reprint based on the Special issue "Molecules in Diabetes Melitus, Dyslipidemia and Cardiovascular Disease”, IJMS journal, MDPI, is to present the impact in clinical practice as well as in medical research of novel molecules that have been introduced in the treatment of diabetes mellitus, dyslipidemia, and cardiovascular disease.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: generalen_US
dc.subject.classificationthema EDItEUR::P Mathematics and Science::PS Biology, life sciencesen_US
dc.subject.othernicotinamide mononucleotide
dc.subject.otherretinal ischemia/reperfusion
dc.subject.otheroxidative stress
dc.subject.otherneuroprotection
dc.subject.otherinflammation
dc.subject.othersacubitril/valsartan
dc.subject.othermortality
dc.subject.othermorbidity
dc.subject.otherheart failure
dc.subject.otherejection fraction
dc.subject.otherdiabetes mellitus
dc.subject.otherα-glucosidase
dc.subject.otherabietane diterpenoids
dc.subject.otherlevopimaric acid
dc.subject.otherquinopimaric acid
dc.subject.othermolecular docking
dc.subject.otherADMET
dc.subject.otherPFK15 synthesis
dc.subject.othersunitinib L-malate
dc.subject.otherHUVEC
dc.subject.otherangiogenesis
dc.subject.othersynergy
dc.subject.othercardiovascular medicine
dc.subject.otherdiabetes
dc.subject.otherhypertension
dc.subject.otherGIP
dc.subject.otherGLP-1
dc.subject.otherglucagon
dc.subject.otherincretins
dc.subject.otherLY3298176
dc.subject.othermeta-analysis
dc.subject.otherobesity
dc.subject.otherSUMMIT
dc.subject.otherSURMOUNT
dc.subject.otherSURPASS
dc.subject.otherSYNERGY
dc.subject.otherTirzepatide
dc.subject.othercommon carotid artery occlusion
dc.subject.otherretinal ischemia
dc.subject.otherdyslipidemia
dc.subject.otherstatin
dc.subject.otherchildren
dc.subject.otheradolescents
dc.subject.othermetabolic syndrome
dc.subject.otherliver
dc.subject.otherhsa-miR-193b-3p
dc.subject.otherperoxisome proliferator activated receptor gamma coactivator 1 alpha
dc.subject.otherlipid metabolism
dc.subject.othern/a
dc.subject.otherempagliflozin
dc.subject.othertype 2 diabetes mellitus
dc.subject.otherleptin
dc.subject.othersphingolipids
dc.subject.othersphingomyelinase
dc.subject.othervasorelaxation
dc.subject.otherendothelial nitric oxide synthase
dc.subject.othertype 2 diabetes
dc.subject.otherthromboxane prostanoid receptor
dc.titleNovel Molecules in Diabetes Melitus, Dyslipidemia and Cardiovascular Disease
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-7684-8
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036576855
oapen.relation.isbn9783036576848
oapen.pages152
oapen.place.publicationBasel


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/4.0/